LANXESS has completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL), a Brazilian biocide manufacturer to strengthen its market position. The competent anti-trust authorities approved the transaction beginning of January 2020.
Manufacturing Antimicrobial Active Ingredients
IPEL is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million-euro range in 2018. With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. LANXESS has taken over the Brazilian company’s laboratory facilities.
IPEL portfolio includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.
About LANXESS
LANXESS is one of the leading specialty chemicals company in the world. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Source: LANXESS